Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes

Journal of Endocrinological Investigation

Volumn 34, Issue 7, 2011, Pages 493-497

  Grugni, G ^a   Giardino, D ^a   Crino A ^b   Malvestiti, F ^a   Ballarati, L ^a   Di Giorgio, G ^b   Marzullo, P ^a,c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

GH; Obesity; Prader Willi syndrome; Type I and type II deletions; Uniparental disomy

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR;

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME 15Q; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS; MALE; OBESITY; PRADER WILLI SYNDROME;

ADOLESCENT; ADULT; ARGININE; CHROMOSOMES, HUMAN, PAIR 15; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; PRADER-WILLI SYNDROME; UNIPARENTAL DISOMY; YOUNG ADULT;

EID: 80054114869     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7203     Document Type: Article

References (34)

1. Bittel DC, Butler MG. Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med 2005, 7: 1-20.
2. rd ed. New York: Springer. 2006, 58-73.
3. Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment Trends Endocrinol Metab 2004, 15: 12-20. (Pubitemid 38198094)
4. Gunay-Aygun M, Heeger S, Schwartz S, Cassidy SB. Delayed diagnosis in patients with Prader-Willi syndrome due to maternal uniparental disomy. Am J Med Genet 1997, 71: 106-10. (Pubitemid 27276708)
5. Roof E, Stone W, MacLean W, Feurer ID, Thompson T, Butler MG. Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res 2000, 44: 25-30. (Pubitemid 30076967)
6. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletions and maternal disomy. Pediatrics 2004, 113: 565-73. (Pubitemid 38280799)
7. Dykens EM, Roof E. Behavior in Prader-Willi syndrome: relationship to genetic subtypes and age. J Child Psychol Psychiatr 2008, 49: 1001-8.
8. Butler MG, Meaney FJ. Standards for selected anthropometric measurements in Prader-Willi families. Pediatrics 1991, 88: 853-60.
9. Lee PDK, Allen DB, Angulo MA, et al. Consensus statement - Prader-Willi syndrome: growth hormone (GH)/insulin-like growth factor axis deficiency and GH treatment. The Endocrinologist 2000, 10 (Suppl 1): 71S-4S. (Pubitemid 30614860)
10. Burman P, Ritzen EM, Lindgren AC. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 2001, 22: 787-99. (Pubitemid 34214295)
11. Partsch CJ, Lämmer C, Gillessen-Kaesbach G, Pankau R. Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion. Growth Horm IGF Res 2000, 10 (Suppl B): S81-5. (Pubitemid 30637221)
12. Grugni G, Guzzaloni G, Morabito F. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome. J Endocrinol Invest 2001, 24: 340-8. (Pubitemid 32492371)
13. Hoybye C, Hilding A, Jacobsson H, Thorén M. Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J Clin Endocrinol Metab 2002, 87: 3590-7.
14. Grugni G, Crinò A, Bertocco P, Marzullo P. Body fat excess and stimulated Growth Hormone levels in adult patients with Prader-Willi syndrome. Am J Med Genet A 2009, 149: 726-31.
15. Grugni G, Marzullo P, Ragusa L, et al. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2006, 65: 492-9. (Pubitemid 44414273)
16. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: Consensus Diagnostic Criteria. Pediatrics 1993, 91: 398-402. (Pubitemid 23042323)
17. Milner KM, Craig EE, Thompson RJ, et al. Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtypes. J Child Psychol Psychiatr 2005, 46: 1089-96. (Pubitemid 44201556)
18. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. Arch Dis Child 1966, 41: 613-35.
19. Ho KKY, on behalf of the 2007 GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 2007, 157: 695-700.
20. Dykens EM, Cassidy SB, King BH. Maladaptive behaviour differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy. Am J Mental Retard 1999, 104: 67-77. (Pubitemid 29394906)
21. Lin H, Lin S, Chuang C, et al. Genotype and phenotype in patients with Prader-Willi syndrome in Taiwan. Acta Paediatr 2007, 96: 902-5. (Pubitemid 46846897)
22. Holsen LM, Zarcone JR, Chambers R, et al. Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. Int J Obes (Lond) 2009, 33: 273-83.
23. Hartley SL, MacLean Jr WE, Butler MG, Zarcone J, Thompson T. Maladaptive behaviors and risk factors among the genetic subtypes of Prader-Willi syndrome. Am J Med Genet A 2005, 136: 140-5. (Pubitemid 40967103)
24. Varela MC, Kok F, Setian N, Kim CA, Koiffmann CP. Impact of molecular mechanisms, including deletion size, on Prader-Willi syndrome phenotype: study of 75 patients. Clin Genet 2005, 67: 47-52.
25. Grugni G, Morabito F, Crinò A. Gonadal function and its disorders in simple obesity and in Prader-Willi syndrome. In: Eiholzer U, l'Allemand D, Zipf WB eds. Prader-Willi syndrome as a model for obesity. Basel: Karger. 2003, 140-55.
26. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML, for The Endocrine Society's Clinical Guidelines Subcommittee. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2006, 91: 1621-34.
27. De Lind van Wijngaarden RF, Otten BJ, Festen DA, et al. High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. J Clin Endocrinol Metab 2008, 93: 1649-54. (Pubitemid 351656500)
28. Aimaretti G, Cornell G, Razzore P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998, 83: 1615-8. (Pubitemid 28501031)
29. Corneli G, Di Somma C, Baldelli R, et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 2005, 153: 257-64. (Pubitemid 41174451)
30. Hartman ML. Physiological regulators of growth hormone secretion. In: Juul A, Jorgensen JOL eds. Growth hormone in adults, 2nd ed. Cambridge University Press: Cambridge. 2000, 3-53.
31. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003, 13: 113-70. (Pubitemid 36986557)
32. Monneret D, Borel J-C, Pepin JL, et al. Pleiotropic role of IGF-I in obesity hypoventilation syndrome. Growth Horm IGF Res 2010, 20: 127-33.
33. Hoybye C. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. Growth Horm IGF Res 2004, 14: 1-15. (Pubitemid 38094239)
34. Bertella L, Mori I, Grugni G, et al. Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study. J Int Disab Res 2007, 51: 302-11. (Pubitemid 46351487)